Salingaros Sophia, Paik Kristine C, Truong Albert Y, Swistel Alexander J, Talmor Mia
From the Division of Plastic and Reconstructive Surgery, Department of Surgery, Weill Cornell Medicine, New York, NY.
Department of Radiology, Weill Cornell Medicine, New York, NY.
Ann Plast Surg. 2025 Jul 1;95(1):33-38. doi: 10.1097/SAP.0000000000004298.
Patients with prior breast augmentation provide an opportunity for capsule preservation and possible direct-to-implant breast reconstruction immediately following nipple-sparing mastectomy (NSM). However, clinical outcomes and postoperative complications remain unclearly described in current literature.
A single reconstructive surgeon retrospective cohort study was conducted on 44 patients (72 breasts) with prior breast augmentation undergoing breast reconstruction following NSM between July 2006 and May 2021. Twenty-nine patients (49 breasts) underwent capsule preservation reconstruction compared with 15 patients (23 breasts) who did not. Demographics, complications, and cosmetic outcomes between the 2 cohorts were reviewed.
Patients with capsule preservation were on average younger at time of NSM (49 years vs 55 years; P = 0.040) and more likely to undergo 1-stage reconstruction (65.5% vs 13.3%; P = 0.001). Cancer recurrence was similar, though lower in the capsule-preserved group (0% vs 13.3%; P = 0.111). There was no significant difference in regard to postoperative complications, with the exception of seromas being more common in the noncapsule preservation group (47.8% vs 6.1%; P < 0.0001). Revision surgery rates were also higher in the noncapsule preservation group, though not statistically significant (52.2% vs 24.5%; P = 0.061). The capsule-preserved group demonstrated comparable nipple aesthetic and overall cosmesis based on the primary author's subjective review.
For patients with prior breast augmentation, preservation of the preexisting capsule during breast reconstruction following NSM is likely safe with no increased risk of cancer recurrence, favorable complication rates, and comparable cosmetic outcomes.
曾接受隆胸手术的患者为保留包膜并在保乳乳头切除术后立即进行直接植入式乳房重建提供了机会。然而,目前文献中对临床结果和术后并发症的描述仍不明确。
对2006年7月至2021年5月期间44例(72侧乳房)曾接受隆胸手术且在保乳乳头切除术后进行乳房重建的患者进行了一项单中心重建外科医生回顾性队列研究。29例患者(49侧乳房)接受了包膜保留重建,而15例患者(23侧乳房)未接受。回顾了两组患者的人口统计学、并发症和美容效果。
保留包膜的患者在保乳乳头切除术时平均年龄较小(49岁 vs 55岁;P = 0.040),且更有可能接受一期重建(65.5% vs 13.3%;P = 0.001)。癌症复发情况相似,尽管保留包膜组较低(0% vs 13.3%;P = 0.111)。术后并发症方面无显著差异,但血清肿在未保留包膜组更常见(47.8% vs 6.1%;P < 0.0001)。未保留包膜组的修复手术率也较高,尽管无统计学意义(52.2% vs 24.5%;P = 0.061)。根据第一作者的主观评价,保留包膜组的乳头美观度和整体美容效果相当。
对于曾接受隆胸手术的患者,在保乳乳头切除术后进行乳房重建时保留原有的包膜可能是安全的,不会增加癌症复发风险,并发症发生率良好,美容效果相当。